Volume 4 Number 3

Website Exclusive Contents!
Exclusive contents: images and/or videos
Editorial
52
Jacques Puel memorial

EuroInterv.2008;4:299

53
Together, we can truly insure the future

EuroInterv.2008;4:301

54
On acquiring decision making skills for endovascular interventions

EuroInterv.2008;4:303-305

EAPCI column
55
"Embargo" on scientific news, a late breaking message from the Ministry of Truth (MiniTrue)

EuroInterv.2008;4:307-308

Focus article
56
Interventional cardiology highlights of the European Society of Cardiology congress, 2008

EuroInterv.2008;4:309-310

Clinical research
57
Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts

EuroInterv.2008;4:311-317

58
Characterisation of the "vulnerable" coronary plaque by multi-detector computed tomography: a correlative study with intravascular ultrasound-derived radiofrequency analysis of plaque composition

EuroInterv.2008;4:318-323

59
Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents

EuroInterv.2008;4:324-330

60
The TandemHeart®, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience

EuroInterv.2008;4:331-337

61
Long-term safety and efficacy are observed after implantation of Zotarolimus-Eluting Stent in real-world clinical practice

EuroInterv.2008;4:338-344

62
"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents

EuroInterv.2008;4:345-350

63
Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis

EuroInterv.2008;4:351-357

64
The "mini-crush technique" for the treatment of coronary trifurcation lesions

EuroInterv.2008;4:358-364

65
Comparison of primary angioplasty in rural and metropolitan areas within an integrated network

EuroInterv.2008;4:365-372

66
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography

EuroInterv.2008;4:373-377

Expert review
67
A primer on the immune system in the pathogenesis and treatment of atherosclerosis

EuroInterv.2008;4:378-390

Experimental research
68
Comparison of drug-eluting stent cell size using micro-CT: important data for bifurcation stent selection

EuroInterv.2008;4:391-396

How should I treat?
69
Stent migration as a late complication following carotid angioplasty and stenting

EuroInterv.2008;4:397-404

Technical report
70
Intrepide™ Trapidil Eluting Stent

EuroInterv.2008;4:405-411

Volume 4 Number 3 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Clearstream Technologies
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Medtronic
  • Terumo
  • Zoll Medical Corporation

Online ISSN 1969-6213 - Print ISSN 1774-024X